TRQI  Anti-virus  Inhibition of intracellular proliferation and enhancement of body immunity of mice infected with influenza virus (Zheng and Gu, 2009). Destroys MRSA biofilm, and induces its death, and when in combined use with vancomycin or linezolid below the MIC concentration (Yang et al., 2018).  Viral pneumonia  A systematic review: TRQI had advantages in response rate of treatment, average length of stay (Pan, 2016).